Linked Data API

Show Search Form

Search Results

789075
registered interest false more like this
date remove maximum value filtermore like thismore than 2017-11-14
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health remove filter
hansard heading General Practitioners: Fees and Charges more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, when the fee chargeable by NHS general practices for providing medical information to patients for the purposes of other public authorities was last reviewed by his Department; and if he will make a statement. more like this
tabling member constituency Oxford East more like this
tabling member printed
Anneliese Dodds more like this
uin 113026 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2017-11-22more like thismore than 2017-11-22
answer text <p>NHS England contracts with general practitioners (GPs) as independent providers of medical services for the National Health Service. Under the terms of their contract, GPs are required to provide certain medical reports or complete certain forms for which a medical report is required by other legislation, for example, the Social Security Administration Act, free of charge to their registered patients.</p><p> </p><p>Outside their contractual requirements, GPs also offer a variety of other services which successive governments have regarded as private matters between the patient and the GP. In such cases, decisions on whether to charge a fee and the level of the fee charged are at the GP’s discretion.</p><p> </p><p>Where legislation requires a medical certificate, or report, the relevant Government Department enters into arrangements with the British Medical Association on the level of fees which will be paid to GPs for providing the required information. Such arrangements are formalised through the provisions of the GP contract.</p><p> </p><p>As these are private arrangements between GP practices and other organisations, the Department does not review the level of fees.</p>
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2017-11-22T14:50:32.33Zmore like thismore than 2017-11-22T14:50:32.33Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
4657
label Biography information for Anneliese Dodds remove filter
789077
registered interest false more like this
date remove maximum value filtermore like thismore than 2017-11-14
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health remove filter
hansard heading General Practitioners: Voluntary Work more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what guidance has been given to NHS general practices on the circumstances under which volunteers are permitted to carry out non-confidential medical work; and whether this guidance is the same as that for permitted activities of volunteers in other parts of the NHS. more like this
tabling member constituency Oxford East more like this
tabling member printed
Anneliese Dodds more like this
uin 113025 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2017-11-22more like thismore than 2017-11-22
answer text <p>NHS England is responsible for ensuring those general practices who provide NHS services are issued with appropriate guidance on the management of volunteers. In September 2017, NHS England published guidance for all National Health Service providers to help them grow and develop volunteering. This equally applies to general practice as to other parts of the NHS. The guidance sets out that providers should include confidentiality and data protection information in a volunteering policy. The volunteer role description set out in the guidance states that all volunteers should ensure that patient confidentiality is maintained at all times.</p><p> </p><p>The guidance is available on the NHS England website:</p><p><a href="https://www.england.nhs.uk/publication/recruiting-and-managing-volunteers-in-nhs-providers-a-practical-guide/" target="_blank">https://www.england.nhs.uk/publication/recruiting-and-managing-volunteers-in-nhs-providers-a-practical-guide/</a></p> more like this
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
question first answered
less than 2017-11-22T17:07:07.547Zmore like thismore than 2017-11-22T17:07:07.547Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
4657
label Biography information for Anneliese Dodds remove filter
789095
registered interest false more like this
date remove maximum value filtermore like thismore than 2017-11-14
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health remove filter
hansard heading Oxford University Hospitals NHS Foundation Trust more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what additional support his Department plans to provide to Oxford University Hospital's NHS Foundation Trust during winter 2017. more like this
tabling member constituency Oxford East more like this
tabling member printed
Anneliese Dodds more like this
uin 112925 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2017-11-22more like thismore than 2017-11-22
answer text <p>NHS Improvement and NHS England are working closely with Oxford University Hospitals NHS Foundation Trust to ensure it is best placed to deal with challenges this winter. This includes working together with local commissioners to ensure services are responsive to patient need and providing support should specific services experience particular pressure. To this end, NHS England and NHS Improvement attend regular joint meetings with local system partners.</p><p> </p><p>In addition, the Emergency Care Improvement Programme team is working to support the local health economy. This includes actions to improve patient flow and urgent care services.</p> more like this
answering member constituency Ludlow more like this
answering member printed Mr Philip Dunne more like this
question first answered
less than 2017-11-22T14:26:30.82Zmore like thismore than 2017-11-22T14:26:30.82Z
answering member
1542
label Biography information for Philip Dunne more like this
tabling member
4657
label Biography information for Anneliese Dodds remove filter
788522
registered interest false more like this
date less than 2017-11-13more like thismore than 2017-11-13
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health remove filter
hansard heading Neuromuscular Disorders: Physiotherapy more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what steps his Department is taking to increase the provision of specialist physiotherapy for children and adults with muscle-wasting conditions. more like this
tabling member constituency Oxford East more like this
tabling member printed
Anneliese Dodds more like this
uin 112488 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2017-11-16more like thismore than 2017-11-16
answer text <p>The provision of specialist physiotherapy for muscle-wasting conditions, or neuromuscular disorders, is a local matter. NHS England has published service specifications for neurological care for both children and adults. These include exemplar service specifications for neuromuscular conditions, inclusive of muscle-wasting conditions, and set out what providers must have in place to offer evidence-based, safe and effective services. This includes access to physiotherapy. This guidance can be found by following the links below:</p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/e09-paedi-neurology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/e09-paedi-neurology.pdf</a></p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/d04-neurosci-spec-neuro.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/d04-neurosci-spec-neuro.pdf</a></p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2017-11-16T12:22:03.357Zmore like thismore than 2017-11-16T12:22:03.357Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
4657
label Biography information for Anneliese Dodds remove filter
758714
registered interest false more like this
date less than 2017-09-07more like thismore than 2017-09-07
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health remove filter
hansard heading Lumacaftor/ivacaftor more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, if he will provide an update on negotiations between NICE and the drug manufacturer Vertex on the potential use of the drug Orkambi. more like this
tabling member constituency Oxford East more like this
tabling member printed
Anneliese Dodds more like this
uin 9489 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2017-09-14more like thismore than 2017-09-14
answer text <p>The National Institute for Health and Care Excellence (NICE) published technology appraisal guidance on the use of lumacaftor-ivacaftor (Orkambi) for the treatment of cystic fibrosis in July 2016. NICE plans to review its guidance to determine whether it should be updated in the light of any new evidence in 2019.</p><p> </p><p>If significant new evidence comes to light before the scheduled review date, NICE has processes in place to bring forward a review. NICE remains open to a further approach from the company, with new evidence or a revised price. Although there has been recent correspondence between NHS England and the company, NICE has not yet received any fresh proposals from the company.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2017-09-14T13:54:44.03Zmore like thismore than 2017-09-14T13:54:44.03Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
4657
label Biography information for Anneliese Dodds remove filter